Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Short Interest Up 124.5% in December

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 3,480,000 shares, a growth of 124.5% from the November 30th total of 1,550,000 shares. Currently, 9.5% of the shares of the stock are short sold. Based on an average daily volume of 6,750,000 shares, the days-to-cover ratio is currently 0.5 days.

Cardio Diagnostics Trading Down 5.6 %

CDIO stock opened at $0.93 on Friday. Cardio Diagnostics has a 1 year low of $0.19 and a 1 year high of $3.56. The company has a 50 day simple moving average of $0.52 and a 200 day simple moving average of $0.44.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.